Linked e-resources
Details
Table of Contents
Part I: Introduction; Chapter 1: Introduction; Part II: Atrial Fibrillation; Chapter 2: CHA2DS2-VASc and HAS-BLED Risk Stratification Tools; Case Introduction; Case Discussion; Risk of Stroke; Risk of Bleeding; How Does a Clinician Choose Among the Various Agents for Stroke Prevention?; Key Points; Self-Assessment Questions; References; Chapter 3: Male with Priority of Ischemic Stroke Reduction; Discussion; Key Points; Self-Assessment Questions; References; Chapter 4: Choosing an Anticoagulant in an Elderly Patient; Case Introduction; Case Discussion; Key Points.
Self-Assessment QuestionsReferences; Chapter 5: Patient with Prior History of GI Hemorrhage; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 6: Patients with a History of Intracranial Hemorrhage; Case Introduction; Key Points; Self-Assessment Questions; References; Chapter 7: Concerns with Anticoagulant Adherence; Key Points; Self-Assessment Questions; References; Chapter 8: Oral Anticoagulants in Stable Moderate Chronic Kidney Disease; Case Introduction; Case Discussion; Background.
What Factors Should be Considered When Selecting an Oral Anticoagulant for Patients with Stable Moderate Renal Function? The Outcome; Key Points; Self-Assessment Questions; References; Chapter 9: Oral Anticoagulants in Severe Renal Dysfunction; Case Discussion; What Is this Patient's Risk of Stroke and Bleeding?; What Is the Evidence for Use of Direct Oral Anticoagulants (DOACs) in Severe CKD?; What Are Considerations When Using Warfarin in CKD?; What Is the Best Anticoagulation Plan for this Patient?; Key Points; Self-Assessment Questions; References.
Chapter 10: Oral Anticoagulants in Patients with Variable Renal Function Case Introduction; Case Discussion; Background; Considerations for DOAC Management in Variable Renal Function; Upon Admission; Case Continuation; Prior to Discharge; Case Continuation; During Hospitalization Follow-up; The Outcome; Key Points; Self-Assessment Questions; References; Chapter 11: Patient with Concomitant Stable Coronary Artery Disease; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 12: Patient with Concomitant Acute Venous Thromboembolism; Case Introduction.
Case Discussion Key Points; Self-Assessment Questions; References; Chapter 13: Patient with Concomitant Mitral Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 14: Patient with Concomitant Aortic Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self Assessment Questions; References; Part III: Warfarin Management; Chapter 15: Best Practice for Switching Stable Warfarin Patients; Case Introduction; Case Discussion; FDA-Approved Indications for Use; Comparison of DOACs with Warfarin.
Self-Assessment QuestionsReferences; Chapter 5: Patient with Prior History of GI Hemorrhage; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 6: Patients with a History of Intracranial Hemorrhage; Case Introduction; Key Points; Self-Assessment Questions; References; Chapter 7: Concerns with Anticoagulant Adherence; Key Points; Self-Assessment Questions; References; Chapter 8: Oral Anticoagulants in Stable Moderate Chronic Kidney Disease; Case Introduction; Case Discussion; Background.
What Factors Should be Considered When Selecting an Oral Anticoagulant for Patients with Stable Moderate Renal Function? The Outcome; Key Points; Self-Assessment Questions; References; Chapter 9: Oral Anticoagulants in Severe Renal Dysfunction; Case Discussion; What Is this Patient's Risk of Stroke and Bleeding?; What Is the Evidence for Use of Direct Oral Anticoagulants (DOACs) in Severe CKD?; What Are Considerations When Using Warfarin in CKD?; What Is the Best Anticoagulation Plan for this Patient?; Key Points; Self-Assessment Questions; References.
Chapter 10: Oral Anticoagulants in Patients with Variable Renal Function Case Introduction; Case Discussion; Background; Considerations for DOAC Management in Variable Renal Function; Upon Admission; Case Continuation; Prior to Discharge; Case Continuation; During Hospitalization Follow-up; The Outcome; Key Points; Self-Assessment Questions; References; Chapter 11: Patient with Concomitant Stable Coronary Artery Disease; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 12: Patient with Concomitant Acute Venous Thromboembolism; Case Introduction.
Case Discussion Key Points; Self-Assessment Questions; References; Chapter 13: Patient with Concomitant Mitral Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 14: Patient with Concomitant Aortic Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self Assessment Questions; References; Part III: Warfarin Management; Chapter 15: Best Practice for Switching Stable Warfarin Patients; Case Introduction; Case Discussion; FDA-Approved Indications for Use; Comparison of DOACs with Warfarin.